GTHP

SEC source: 0001477932-24-005458 · form4.xml · derivative · entry 3

Grujic Alan · CIK 0001980904 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 800,000 shares

Expires 2024-09-02

F3 · kind: Warrants to purchase an aggregate of 800,000 shares of Common Stock at $0.50 per share expired on September 2, 2024.

F3 · price: Warrants to purchase an aggregate of 800,000 shares of Common Stock at $0.50 per share expired on September 2, 2024.

SEC source: 0001477932-24-006656 · form4.xml · derivative · entry 2

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,600,000

Underlying: Common shares · 900,000 shares

Expires 2027-09-01

F1 · kind: On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended on September 30, 2021 and November 11, 2022. As a result of the consulting agreement Mr. Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches. The common stock and warrants from the fourth tranche were issued on September 1, 2024 and October 14, 2024, respectively.

F1 · price: On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended on September 30, 2021 and November 11, 2022. As a result of the consulting agreement Mr. Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches. The common stock and warrants from the fourth tranche were issued on September 1, 2024 and October 14, 2024, respectively.

SEC source: 0001477932-24-005207 · form4.xml · nonDerivative · entry 1

Imhoff John E · CIK 0001348439 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,409,231

F1 · kind: These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.1093.

F1 · price: These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.1093.

SEC source: 0001477932-24-005206 · form4.xml · nonDerivative · entry 1

Blumberg Richard P. · CIK 0001486345 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,289,725

F1 · kind: These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.1093.

F1 · price: These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.1093.

SEC source: 0001477932-24-005227 · form4.xml · nonDerivative · entry 1

Grujic Alan · CIK 0001980904 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,448,025

F1 · kind: These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.1093.

F1 · price: These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.1093.

SEC source: 0001477932-24-005604 · form4.xml · derivative · entry 2

JAMES MICHAEL C · CIK 0001365831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2028-08-01

F2 · kind: On August 2, 2024, the Company issued a $25,000 note payable to Mr. James. In conjunction with the note, the Company also issued four-year warrants to purchase an aggregate of 25,000 shares of Common Stock at $0.25 per share.

F2 · price: On August 2, 2024, the Company issued a $25,000 note payable to Mr. James. In conjunction with the note, the Company also issued four-year warrants to purchase an aggregate of 25,000 shares of Common Stock at $0.25 per share.

SEC source: 0001477932-24-005458 · form4.xml · derivative · entry 2

Grujic Alan · CIK 0001980904 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2028-07-30

F2 · kind: On July 31, 2024, the Company issued a $25,000 note payable to Mr. Grujic. In conjunction with the note, the Company also issued four-year warrants to purchase an aggregate of 25,000 shares of Common Stock at $0.25 per share.

F2 · price: On July 31, 2024, the Company issued a $25,000 note payable to Mr. Grujic. In conjunction with the note, the Company also issued four-year warrants to purchase an aggregate of 25,000 shares of Common Stock at $0.25 per share.

SEC source: 0001477932-24-005592 · form4.xml · derivative · entry 2

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2028-07-30

F2 · kind: On July 31, 2024, the Company issued a $25,000 note payable to Mr. Imhoff. In conjunction with the note, the Company also issued four-year warrants to purchase an aggregate of 25,000 shares of Common Stock at $0.25 per share.

F2 · price: On July 31, 2024, the Company issued a $25,000 note payable to Mr. Imhoff. In conjunction with the note, the Company also issued four-year warrants to purchase an aggregate of 25,000 shares of Common Stock at $0.25 per share.

SEC source: 0001477932-24-004509 · form4.xml · nonDerivative · entry 1

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,226,223

F1 · kind: These shares were issued for payment of accrued dividends on the reporting individual's Series D preferred stock, at a conversion price of $0.1164.

F1 · price: These shares were issued for payment of accrued dividends on the reporting individual's Series D preferred stock, at a conversion price of $0.1164.

SEC source: 0001477932-24-005458 · form4.xml · derivative · entry 1

Grujic Alan · CIK 0001980904 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2034-07-08

F1 · derivative.exercise_date: One-fourth of the shares subject to the award vested on July 9, 2024; the remaining shares will vest monthly, starting on October 9, 2024, subject to the reporting person's continued service on each such date, until the award is fully vested on July 8, 2027.

SEC source: 0001477932-24-005518 · form4.xml · derivative · entry 1

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 100,000 shares

Expires 2034-07-08

F1 · derivative.exercise_date: One-fourth of the shares subject to the award vested on July 9, 2024; the remaining shares will vest monthly, starting on October 9, 2024, subject to the reporting person's continued service on each such date, until the award is fully vested on July 8, 2027.

SEC source: 0001477932-24-005592 · form4.xml · derivative · entry 1

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 100,000 shares

Expires 2034-07-08

F1 · derivative.exercise_date: One-fourth of the shares subject to the award vested on July 9, 2024; the remaining shares will vest monthly, starting on October 9, 2024, subject to the reporting person's continued service on each such date, until the award is fully vested on July 8, 2027.

SEC source: 0001477932-24-005604 · form4.xml · derivative · entry 1

JAMES MICHAEL C · CIK 0001365831 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 100,000 shares

Expires 2034-07-08

F1 · derivative.exercise_date: One-fourth of the shares subject to the award vested on July 9, 2024; the remaining shares will vest monthly, starting on October 9, 2024, subject to the reporting person's continued service on each such date, until the award is fully vested on July 8, 2027.

SEC source: 0001477932-24-002247 · form4.xml · nonDerivative · entry 2

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,177,896

F2 · kind: These shares were issued for payment of accrued dividends on the reporting individual's Series D preferred stock, at a conversion price of $0.1157.

F2 · price: These shares were issued for payment of accrued dividends on the reporting individual's Series D preferred stock, at a conversion price of $0.1157.

SEC source: 0001477932-24-001900 · form4.xml · nonDerivative · entry 2

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,119,162

F2 · kind: These shares were issued for payment of accrued dividends on the reporting individual's Series F-2 preferred stock, at a conversion price of $0.1361.

F2 · price: These shares were issued for payment of accrued dividends on the reporting individual's Series F-2 preferred stock, at a conversion price of $0.1361.

SEC source: 0001477932-24-001900 · form4.xml · nonDerivative · entry 1

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,080,269

F1 · kind: These shares were issued for payment of accrued dividends on the reporting individual's Series F preferred stock, at a conversion price of $0.1361.

F1 · price: These shares were issued for payment of accrued dividends on the reporting individual's Series F preferred stock, at a conversion price of $0.1361.

SEC source: 0001477932-24-002247 · form4.xml · nonDerivative · entry 1

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,129,258

F1 · kind: These shares were issued for payment of accrued dividends on the reporting individual's Series F preferred stock, at a conversion price of $0.1361.

F1 · price: These shares were issued for payment of accrued dividends on the reporting individual's Series F preferred stock, at a conversion price of $0.1361.

SEC source: 0001477932-24-001435 · form4.xml · derivative · entry 2

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,700,000

Underlying: Common shares · 900,000 shares

Expires 2027-03-01

F1 · kind: On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended on September 30, 2021 and November 11, 2022. As a result of the consulting agreement Mr. Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches. The third tranche was issued on March 1, 2024 and was due 18 months after the Company obtained the requisite financing. The remaining tranche is due September 2024.

F1 · price: On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended on September 30, 2021 and November 11, 2022. As a result of the consulting agreement Mr. Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches. The third tranche was issued on March 1, 2024 and was due 18 months after the Company obtained the requisite financing. The remaining tranche is due September 2024.

SEC source: 0001477932-24-001435 · form4.xml · nonDerivative · entry 1

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,965,357

F1 · kind: On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended on September 30, 2021 and November 11, 2022. As a result of the consulting agreement Mr. Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches. The third tranche was issued on March 1, 2024 and was due 18 months after the Company obtained the requisite financing. The remaining tranche is due September 2024.

F1 · price: On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended on September 30, 2021 and November 11, 2022. As a result of the consulting agreement Mr. Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches. The third tranche was issued on March 1, 2024 and was due 18 months after the Company obtained the requisite financing. The remaining tranche is due September 2024.

SEC source: 0001477932-24-000856 · form4.xml · nonDerivative · entry 2

Imhoff John E · CIK 0001348439 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,124,838

F2 · kind: These shares were issued for payment of accrued dividends on the reporting individual's Series D preferred stock, at a conversion price of $0.1507.

F2 · price: These shares were issued for payment of accrued dividends on the reporting individual's Series D preferred stock, at a conversion price of $0.1507.

SEC source: 0001477932-23-009031 · form4.xml · derivative · entry 5

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common shares · 1,642,500 shares

Expires 2023-12-01

F1 · price: During November 2023, Mr. Blumberg signed an exchange agreement to exchange 1,825,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 1,642,500 warrants to purchase shares of common stock for an exercise price of $0.12. The newly exchanged warrants were subsequently exercised upon payment of $197,100.

SEC source: 0001477932-23-009031 · form4.xml · nonDerivative · entry 1

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,565,357

F1 · price: During November 2023, Mr. Blumberg signed an exchange agreement to exchange 1,825,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 1,642,500 warrants to purchase shares of common stock for an exercise price of $0.12. The newly exchanged warrants were subsequently exercised upon payment of $197,100.

SEC source: 0001477932-23-009031 · form4.xml · derivative · entry 4

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,642,500

Underlying: Common shares · 1,642,500 shares

Expires 2023-12-01

F1 · kind: During November 2023, Mr. Blumberg signed an exchange agreement to exchange 1,825,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 1,642,500 warrants to purchase shares of common stock for an exercise price of $0.12. The newly exchanged warrants were subsequently exercised upon payment of $197,100.

F1 · price: During November 2023, Mr. Blumberg signed an exchange agreement to exchange 1,825,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 1,642,500 warrants to purchase shares of common stock for an exercise price of $0.12. The newly exchanged warrants were subsequently exercised upon payment of $197,100.

SEC source: 0001477932-23-009031 · form4.xml · derivative · entry 3

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common shares · 950,000 shares

Expires 2024-01-01

F1 · kind: During November 2023, Mr. Blumberg signed an exchange agreement to exchange 1,825,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 1,642,500 warrants to purchase shares of common stock for an exercise price of $0.12. The newly exchanged warrants were subsequently exercised upon payment of $197,100.

F1 · price: During November 2023, Mr. Blumberg signed an exchange agreement to exchange 1,825,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 1,642,500 warrants to purchase shares of common stock for an exercise price of $0.12. The newly exchanged warrants were subsequently exercised upon payment of $197,100.

SEC source: 0001477932-23-009031 · form4.xml · derivative · entry 2

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common shares · 875,000 shares

Expires 2023-12-31

F1 · kind: During November 2023, Mr. Blumberg signed an exchange agreement to exchange 1,825,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 1,642,500 warrants to purchase shares of common stock for an exercise price of $0.12. The newly exchanged warrants were subsequently exercised upon payment of $197,100.

F1 · price: During November 2023, Mr. Blumberg signed an exchange agreement to exchange 1,825,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 1,642,500 warrants to purchase shares of common stock for an exercise price of $0.12. The newly exchanged warrants were subsequently exercised upon payment of $197,100.

SEC source: 0001477932-24-000856 · form4.xml · nonDerivative · entry 1

Imhoff John E · CIK 0001348439 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,087,514

F1 · kind: These shares were issued for payment of accrued dividends on the reporting individual's Series D preferred stock, at a conversion price of $0.1504.

F1 · price: These shares were issued for payment of accrued dividends on the reporting individual's Series D preferred stock, at a conversion price of $0.1504.

SEC source: 0001477932-23-006982 · form4.xml · derivative · entry 3

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,800,000

Underlying: Common Shares · 900,000 shares

Expires 2026-09-01

F2 · kind: On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended during the year ended December 31, 2021. As a result of the consulting agreement Mr.Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches. The second tranche was issued on September 1, 2023 and was due 12 months after the Company obtained the requisite financing. The remaining two tranches are due in six-month installments until the final tranche is issued in September 2024.

F2 · price: On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended during the year ended December 31, 2021. As a result of the consulting agreement Mr.Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches. The second tranche was issued on September 1, 2023 and was due 12 months after the Company obtained the requisite financing. The remaining two tranches are due in six-month installments until the final tranche is issued in September 2024.

SEC source: 0001477932-23-006982 · form4.xml · nonDerivative · entry 2

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,922,857

F2 · kind: On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended during the year ended December 31, 2021. As a result of the consulting agreement Mr.Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches. The second tranche was issued on September 1, 2023 and was due 12 months after the Company obtained the requisite financing. The remaining two tranches are due in six-month installments until the final tranche is issued in September 2024.

F2 · price: On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended during the year ended December 31, 2021. As a result of the consulting agreement Mr.Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches. The second tranche was issued on September 1, 2023 and was due 12 months after the Company obtained the requisite financing. The remaining two tranches are due in six-month installments until the final tranche is issued in September 2024.

SEC source: 0001477932-23-006714 · form4.xml · nonDerivative · entry 3

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,050,104

F4 · kind: These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.1777.

F4 · price: These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.1777.

SEC source: 0001477932-23-006793 · form4.xml · nonDerivative · entry 1

Grujic Alan · CIK 0001980904 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,411,423

F1 · kind: These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.1777.

F1 · price: These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.1777.

SEC source: 0001477932-23-006982 · form4.xml · nonDerivative · entry 1

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 3,522,857

F1 · kind: These shares were issued for payment of accrued dividends on WMB Pension Plan's Series E preferred stock, at a conversion price of $0.1777. WMB Pension Plan is beneficially owned by Rick Blumberg, the reporting individual.

F1 · price: These shares were issued for payment of accrued dividends on WMB Pension Plan's Series E preferred stock, at a conversion price of $0.1777. WMB Pension Plan is beneficially owned by Rick Blumberg, the reporting individual.

F1 · ownership.nature: These shares were issued for payment of accrued dividends on WMB Pension Plan's Series E preferred stock, at a conversion price of $0.1777. WMB Pension Plan is beneficially owned by Rick Blumberg, the reporting individual.

SEC source: 0001477932-23-006714 · form4.xml · derivative · entry 4

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250

Underlying: Common Stock · 1,000,000 shares

Expires not disclosed

F2 · kind: These shares were issued as part of Common Stock Purchase Agreement signed between Dr. Imhoff and Rosalind Master Fund, LLP, on August 3, 2023. For a price of $150,090, Dr. Imhoff purchased 500,899 shares of Guided Therapeutics' (GTHP) common stock, par value $0.001 and 250 shares of GTHP Series E Convertible Preferred Stock (see (3)).

F2 · price: These shares were issued as part of Common Stock Purchase Agreement signed between Dr. Imhoff and Rosalind Master Fund, LLP, on August 3, 2023. For a price of $150,090, Dr. Imhoff purchased 500,899 shares of Guided Therapeutics' (GTHP) common stock, par value $0.001 and 250 shares of GTHP Series E Convertible Preferred Stock (see (3)).

F3 · derivative.expiration_date: These securities consist of Series E Convertible Preferred Stock ("Series E Preferred") of the Issuer that are presently convertible on a 1-for-4,000 basis into Common Stock without payment or further consideration. The Series E Preferred shares are convertible at any time until 8/21/2025. The Series E Preferred has no expiration date.

SEC source: 0001477932-23-006714 · form4.xml · nonDerivative · entry 2

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,937,536

F2 · kind: These shares were issued as part of Common Stock Purchase Agreement signed between Dr. Imhoff and Rosalind Master Fund, LLP, on August 3, 2023. For a price of $150,090, Dr. Imhoff purchased 500,899 shares of Guided Therapeutics' (GTHP) common stock, par value $0.001 and 250 shares of GTHP Series E Convertible Preferred Stock (see (3)).

F2 · price: These shares were issued as part of Common Stock Purchase Agreement signed between Dr. Imhoff and Rosalind Master Fund, LLP, on August 3, 2023. For a price of $150,090, Dr. Imhoff purchased 500,899 shares of Guided Therapeutics' (GTHP) common stock, par value $0.001 and 250 shares of GTHP Series E Convertible Preferred Stock (see (3)).

SEC source: 0001477932-23-006714 · form4.xml · nonDerivative · entry 1

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,436,637

F1 · kind: These shares were issued for payment of accrued dividends on the reporting individual's Series D preferred stock, at a conversion price of $0.2139.

F1 · price: These shares were issued for payment of accrued dividends on the reporting individual's Series D preferred stock, at a conversion price of $0.2139.

SEC source: 0001477932-23-004759 · form4.xml · nonDerivative · entry 1

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,410,336

F1 · kind: These shares were issued for payment of accrued dividends on the reporting individual's Series D preferred stock, at a conversion price of $0.2512.

F1 · price: These shares were issued for payment of accrued dividends on the reporting individual's Series D preferred stock, at a conversion price of $0.2512.

SEC source: 0001477932-23-004807 · form4.xml · nonDerivative · entry 3

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,417,943

F3 · kind: These shares were issued for payment of accrued dividends on the reporting individual's Series F and Series F-2 preferred stock, at a conversion price of $0.2712.

F3 · price: These shares were issued for payment of accrued dividends on the reporting individual's Series F and Series F-2 preferred stock, at a conversion price of $0.2712.

SEC source: 0001477932-23-004807 · form4.xml · nonDerivative · entry 2

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,340,965

F2 · price: During February 2023, Mr. Blumberg signed an exchange agreement to exchange 875,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 831,250 warrants to purchase shares of common stock for an exercise price of $0.20. The newly exchanged warrants were subsequently exercised upon payment of $166,250.

SEC source: 0001477932-23-004807 · form4.xml · derivative · entry 7

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 900,000

Underlying: Common Shares · 900,000 shares

Expires 2026-03-01

F2 · kind: During February 2023, Mr. Blumberg signed an exchange agreement to exchange 875,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 831,250 warrants to purchase shares of common stock for an exercise price of $0.20. The newly exchanged warrants were subsequently exercised upon payment of $166,250.

F1 · price: On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended during the year ended December 31, 2021. As a result of the consulting agreement Mr. Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches, the first of which was issued on March 1, 2023 and was due 6 months after the Company obtained the requisite financing. The remaining tranches are due in six-month installments until the final tranche is issued in September 2024.

SEC source: 0001477932-23-004807 · form4.xml · nonDerivative · entry 1

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,509,715

F1 · kind: On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended during the year ended December 31, 2021. As a result of the consulting agreement Mr. Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches, the first of which was issued on March 1, 2023 and was due 6 months after the Company obtained the requisite financing. The remaining tranches are due in six-month installments until the final tranche is issued in September 2024.

F1 · price: On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended during the year ended December 31, 2021. As a result of the consulting agreement Mr. Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches, the first of which was issued on March 1, 2023 and was due 6 months after the Company obtained the requisite financing. The remaining tranches are due in six-month installments until the final tranche is issued in September 2024.

SEC source: 0001477932-23-004807 · form4.xml · derivative · entry 6

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common shares · 831,250 shares

Expires 2023-03-15

F2 · price: During February 2023, Mr. Blumberg signed an exchange agreement to exchange 875,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 831,250 warrants to purchase shares of common stock for an exercise price of $0.20. The newly exchanged warrants were subsequently exercised upon payment of $166,250.

SEC source: 0001477932-23-004807 · form4.xml · derivative · entry 5

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 831,250

Underlying: Common shares · 831,250 shares

Expires 2023-03-15

F2 · kind: During February 2023, Mr. Blumberg signed an exchange agreement to exchange 875,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 831,250 warrants to purchase shares of common stock for an exercise price of $0.20. The newly exchanged warrants were subsequently exercised upon payment of $166,250.

F2 · price: During February 2023, Mr. Blumberg signed an exchange agreement to exchange 875,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 831,250 warrants to purchase shares of common stock for an exercise price of $0.20. The newly exchanged warrants were subsequently exercised upon payment of $166,250.

SEC source: 0001477932-23-004807 · form4.xml · derivative · entry 4

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,825,000

Underlying: Common shares · 875,000 shares

Expires 2023-02-22

F2 · kind: During February 2023, Mr. Blumberg signed an exchange agreement to exchange 875,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 831,250 warrants to purchase shares of common stock for an exercise price of $0.20. The newly exchanged warrants were subsequently exercised upon payment of $166,250.

F2 · price: During February 2023, Mr. Blumberg signed an exchange agreement to exchange 875,000 warrants to purchase shares of common stock for an exercise price of $0.25, for 831,250 warrants to purchase shares of common stock for an exercise price of $0.20. The newly exchanged warrants were subsequently exercised upon payment of $166,250.

SEC source: 0001477932-23-004226 · form4.xml · derivative · entry 1

JAMES MICHAEL C · CIK 0001365831 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 100,000 shares

Expires 2033-02-09

F1 · derivative.exercise_date: One-fourth of the shares subject to the award vested on February 10, 2023; the remaining shares will vest monthly, subject to the reporting person's continued service on each such date, until the award is fully vested on February 9, 2026.

SEC source: 0001477932-23-004758 · form4.xml · derivative · entry 1

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2033-02-09

F1 · price: One-fourth of the shares subject to the award vested on February 10, 2023; the remaining shares will vest monthly, subject to the reporting person's continued service on each such date, until the award is fully vested on February 9, 2026.

SEC source: 0001477932-23-004806 · form4.xml · derivative · entry 1

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2033-02-09

F1 · price: One-fourth of the shares subject to the award vested on February 10, 2023; the remaining shares will vest monthly, following 90 days from the grant date, subject to the reporting person's continued service on each such date, until the award is fully vested on February 10, 2026.

SEC source: 0001477932-23-004805 · form4.xml · derivative · entry 1

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,700,000

Underlying: Common shares · 950,000 shares

Expires 2024-01-01

F1 · kind: On September 30, 2021, the Company entered into a Consulting Agreement with Richard Blumberg pursuant to which the Company agreed to issue 950,000 warrants to purchase an aggregate of 950,000 shares of common stock for $0.25 per share. Issuance of the warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The Company obtained the requisite financing and the warrants were issued on December 1, 2022. The warrants will expire on January 1, 2024 if they are not exercised.

F1 · price: On September 30, 2021, the Company entered into a Consulting Agreement with Richard Blumberg pursuant to which the Company agreed to issue 950,000 warrants to purchase an aggregate of 950,000 shares of common stock for $0.25 per share. Issuance of the warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The Company obtained the requisite financing and the warrants were issued on December 1, 2022. The warrants will expire on January 1, 2024 if they are not exercised.

SEC source: 0001477932-23-004225 · form4.xml · nonDerivative · entry 1

JAMES MICHAEL C · CIK 0001365831 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,772

F1 · price: On September 1, 2022, the Company entered into a Securities Purchase Agreements with Mr. James pursuant to which the Company issued 100,000 shares of its common stock, four year warrants to purchase an aggregate of 100,000 shares of Common Stock at $0.50 per share and 100,000 shares of Common Stock at $0.65 per share for an aggregate purchase price of $50,000.

SEC source: 0001477932-23-004757 · form4.xml · nonDerivative · entry 1

Imhoff John E · CIK 0001348439 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,356,532

F1 · price: On September 1, 2022, the Company entered into a Securities Purchase Agreements with Mr. Imhoff pursuant to which the Company issued 500,000 shares of its common stock, four-year warrants to purchase an aggregate of 500,000 shares of common stock for $0.50 per share and four-year warrants to purchase 500,000 shares of common stock for $0.65 per share for an aggregate purchase price of $250,000.

SEC source: 0001477932-23-004804 · form4.xml · nonDerivative · entry 1

Blumberg Richard P. · CIK 0001486345 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,109,715

F1 · price: On September 1, 2022, the Company entered into a Securities Purchase Agreements with Mr. Blumberg pursuant to which the Company issued 1,000,000 shares of its common stock, four-year warrants to purchase an aggregate of 1,000,000 shares of common stock for $0.50 per share and four-year warrants to purchase 1,000,000 shares of common stock for $0.65 per share for an aggregate purchase price of $500,000.

SEC source: 0001477932-23-004225 · form4.xml · derivative · entry 3

JAMES MICHAEL C · CIK 0001365831 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2026-09-01

F1 · price: On September 1, 2022, the Company entered into a Securities Purchase Agreements with Mr. James pursuant to which the Company issued 100,000 shares of its common stock, four year warrants to purchase an aggregate of 100,000 shares of Common Stock at $0.50 per share and 100,000 shares of Common Stock at $0.65 per share for an aggregate purchase price of $50,000.